Senores Pharmaceuticals IPO: Key Details, GMP, and Investment Insights

The much-anticipated Senores Pharmaceuticals IPO has garnered significant attention from investors. Known for its innovations in the pharmaceutical industry, Senores Pharmaceuticals is now stepping into the capital markets, offering a promising opportunity for both retail and institutional investors. This article delves into the IPO's details, including allotment dates, status, and everything you need to know.

Company Overview

Senores Pharmaceuticals, a rapidly growing player in the pharmaceutical industry, specializes in the development and production of high-quality generic drugs. With a strong presence in both domestic and international markets, the company has shown remarkable growth in recent years. Its IPO aims to fund expansion plans, repay debts, and strengthen its manufacturing capabilities.

IPO Key Details

Here are the vital details about the Senores Pharmaceuticals IPO:

IPO Open and Close Dates:
- Subscription started on December 20, 2024, and closed on December 24, 2024.
Price Band:
- The price range for the IPO was set at ₹372 to ₹391 per share.
Lot Size:
- Investors could bid in lots of 38 shares, with a minimum investment of approximately ₹14,896.
Issue Size:
- The IPO comprised a ₹500 crore fresh issue and an ₹82.11 crore offer for sale, totaling ₹582.11 crore.
Oversubscription:
- The IPO saw a stellar response, oversubscribed by 93.69 times, with strong interest from Qualified Institutional Buyers (QIBs).
Listing Date:
- Shares are expected to list on December 30, 2024, on both the BSE and NSE.

Allotment Date and Status

When Is the Allotment Date?

The allotment of shares will be finalized on December 26, 2024. Investors eagerly await to see if their applications have been successful.

How to Check Allotment Status?

Once the allotment is finalized, investors can check their status through the IPO's registrar, Link Intime India Private Limited. Here’s how:

Visit the Registrar’s Website:
Go to the Link Intime India website.
Navigate to Allotment Status Section:
Find the 'IPO Allotment Status' page.
Select IPO Name:
From the dropdown menu, choose "Senores Pharmaceuticals IPO."
Enter Required Details:
Input your PAN number, application number, or DP Client ID.
Submit and View Status:
Click on "Submit" to see if you’ve been allotted shares.

Grey Market Premium (GMP)

The Grey Market Premium (GMP) for Senores Pharmaceuticals IPO has shown robust activity. As of the latest updates, the GMP stands at ₹195 to ₹205, indicating strong demand and the likelihood of a premium listing.

Financial Highlights

Revenue Growth

The company reported a revenue of ₹217.34 crore in FY 2024, marking substantial growth from ₹39.02 crore in FY 2023.

Net Profit/Loss

Despite impressive revenue growth, the company posted a net loss of ₹32.71 crore in FY 2024, compared to a profit of ₹8.43 crore in FY 2023. The funds raised from the IPO are expected to help address financial challenges and pave the way for future profitability.

Reasons to Invest in Senores Pharmaceuticals IPO

Strong Industry Position:
The company is a key player in the growing generic pharmaceutical market.
Global Reach:
With exports contributing significantly to its revenue, Senores is well-positioned for global expansion.
Growth Potential:
The IPO proceeds will fund capacity expansion, enabling the company to meet rising demand.
High Investor Interest:
The oversubscription rate underscores strong confidence in the company’s prospects.

Risks to Consider

While the IPO has generated enthusiasm, potential investors should also be aware of the associated risks:

Financial Losses:
The company’s recent losses may affect its short-term financial stability.
Regulatory Challenges:
The pharmaceutical industry faces strict regulations, which could impact operations.
Market Competition:
Increased competition in the generic drug market could pressure margins.

FAQs About Senores Pharmaceuticals IPO

1. What is the allotment date for Senores Pharmaceuticals IPO?

The allotment of shares is scheduled for December 26, 2024.

2. How can I check the allotment status?

You can check the allotment status on the Link Intime India website by entering your PAN, application number, or DP Client ID.

3. When will the shares be listed on the stock exchange?

The shares will be listed on the BSE and NSE on December 30, 2024.

4. What is the IPO price band?

The price band for the IPO is ₹372 to ₹391 per share.

5. What is the minimum investment required?

The minimum investment for one lot (38 shares) is approximately ₹14,896.

6. How was the subscription response to the IPO?

The IPO was oversubscribed by 93.69 times, with strong demand across all investor categories.

7. What is the Grey Market Premium (GMP) for this IPO?

The GMP is currently between ₹195 and ₹205, suggesting a strong premium on listing.

8. What are the objectives of the IPO?

The IPO aims to fund capacity expansion, repay debts, and meet general corporate expenses.

Final Thoughts

The Senores Pharmaceuticals IPO offers an exciting opportunity for investors, backed by strong industry prospects and overwhelming subscription demand. However, potential investors should carefully consider the company’s financial position and market risks before making a decision. With the allotment date nearing and a premium listing expected, the IPO remains a focal point in the investment community.

Stay updated with the latest developments and ensure you follow proper channels to check your allotment status. Happy investing!

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please conduct your own research or consult a financial expert before investing.

Next Carraro India IPO: Key Details and Investor Insights

Next Hamps Bio IPO Allotment Status: Key Details and Updates

Next Bloodborne 2 Announced: PlayStation's Bold 2024 Moves

Senores Pharmaceuticals IPO: Key Details, GMP, and Investment Insights